Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
August 22 2023 - 8:05AM
TRxADE HEALTH, Inc. (NASDAQ: MEDS), a pharmaceutical exchange
platform provider that recently merged with food technology and
distribution company Superlatus, Inc., today entered into a binding
agreement to acquire The Urgent Company, Inc. and its Coolhaus,
Brave Robot, Modern Kitchen and California Performance Co. consumer
brands from Perfect Day, Inc.
The acquisition is expected to strengthen
Superlatus’ leadership in the production of sustainable and
equitable food products and enable the combined company to more
readily enter new markets and expand market share.
As part of the acquisition, Natasha Case,
Founder of Coolhaus will rejoin the brand as Chief Brand Officer
and will also be an advisor to Superlatus’ broader portfolio of
brands.
This deal will continue to accelerate the
expansion of the acquired brands’ retail footprint. The acquired
brands’ products are sold in more than 6,000 stores nationwide
including Whole Foods, Thrive Market, Kroger, and Costco as well as
many independent markets across the country.
“We are excited to welcome the Coolhaus, Brave
Robot, Modern Kitchen and California Performance Co. brands to our
portfolio of CPG assets,” said Superlatus interim CEO Tim Alford.
“Together, our shared interest in the sustainable and equitable
food sectors will, we believe, allow us to expand our market
presence and pursue a number of new opportunities to grow our
brands together.”
“In addition, once complete, this acquisition
will help accelerate both companies’ environmental mission to
transition our products to animal free in the months and years
ahead.”
The Urgent Company general manager and
co-founder Paul Kollesoff added, "Bringing together our companies’
social and climate missions is deeply meaningful to us. We believe
the work we do now will determine if our children can continue to
enjoy the food we eat and the planet we inhabit for years to come.
This deal also directly speaks to the value The Urgent Company has
created in the precision fermentation category and will help
continue to satisfy the growing consumer appetite for these
delicious, sustainable products."
About The
Urgent Company
The Urgent Company is a new type of CPG company,
one with a singular focus on the next generation of consumer brands
that harness the latest in innovation and science to create
revolutionary, delicious, and sustainable animal-free foods with
less impact on the planet. The Urgent Company made its marketplace
premiere with the launch of Brave Robot, a revolutionary ice cream
made with Perfect Day's non-animal whey protein, which uses science
and a little bit of technology to remove animals from the equation
without sacrificing the indulgent taste and texture of dairy. The
Urgent Company strives to be different, while making a difference.
They exist for the future and believe that if things don't change
now, there will be nothing left for tomorrow. Visit
theurgentcompany.com to learn more.
About Superlatus,
Inc.
Superlatus is a diversified food technology
company with distribution capabilities. We scale food innovation
and transformational change to our food systems to optimize food
security and population health via innovative CPG products,
agritech, foodtech, plant-based proteins and alt- proteins. We
provide industry-leading processing and forming technologies that
create high nutrition, high taste, and textured foods. Our
management team consists of world-class food executives with an
unparalleled understanding of technology and taste. For more
information on Superlatus, please visit Superlatus’ website at
https://www.superlatusfoods.com.
About TRxADE
HEALTH, INC.
TRxADE HEALTH (NASDAQ: MEDS) is a health
services IT company focused on digitalizing the retail pharmacy
experience by optimizing drug procurement, the prescription journey
and patient engagement in the U.S. The Company operates the TRxADE
drug procurement marketplace serving approximately 14,500+ members
nationwide, fostering price transparency and under the Bonum Health
brand, offering patient centric telehealth services. The Company
plans to exit the health services IT business. For more information
on TRxADE HEALTH, please visit the Company’s IR websiteat
investors.trxadegroup.com.
Forward-Looking Statements
This press release contains certain statements
that may be deemed to be “forward-looking statements” within the
federal securities laws, including the safe harbor provisions under
the Private Securities Litigation Reform Act of 1995. Statements
that are not historical are forward- looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934. Forward-looking
statements relate to future events or our future performance or
future financial condition. These forward-looking statements are
not historical facts, but rather are based on current expectations,
estimates and projections about our company, our industry, our
beliefs and our assumptions. Such forward-looking statements
include, but are not limited to, statements regarding our or our
management team’s expectations, hopes, beliefs, intentions or
strategies regarding the future. In addition, any statements that
refer to projections, forecasts or other characterizations of
future events or circumstances, including any underlying
assumptions, are forward-looking statements. In some cases, you can
identify forward-looking statements by the following words:
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intend,” “may,” “ongoing,” “plan,” “potential,” “predict,”
“project,” “should,” or the negative of these terms or other
similar expressions, but the absence of these words does not mean
that a statement is not forward-looking. Forward-looking statements
are subject to a number of risks and uncertainties (some of which
are beyond our control) that may cause actual results or
performance to be materially different from those expressed or
implied by such forward-looking statements. Accordingly, readers
should not place undue reliance on any forward-looking statements.
These risks include risks relating to agreements with third
parties; our ability to raise funding in the future, as needed, and
the terms of such funding, including potential dilution caused
thereby; our ability to continue as a going concern; security
interests under certain of our credit arrangements; our ability to
maintain the listing of our common stock on the Nasdaq Capital
Market; claims relating to alleged violations of intellectual
property rights of others; the outcome of any current legal
proceedings or future legal proceedings that may be instituted
against us; unanticipated difficulties or expenditures relating to
our business plan; and those risks detailed in TRxADE’s most recent
Annual Report on Form 10-K and subsequent reports filed with the
Securities and Exchange Commission.
Forward-looking statements speak only as of the
date they are made. The TRxADE undertakes no obligation to update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise that occur after that
date, except as otherwise provided by law.
Investor Contact: Skyline Corporate
Communications Group, LLC Scott Powell, President One Rockefeller
Plaza, 11th FloorNew York, NY 10020 Office: (646) 893-5835 Email:
info@skylineccg.com
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Feb 2025 to Mar 2025
TRxADE Health (NASDAQ:MEDS)
Historical Stock Chart
From Mar 2024 to Mar 2025